Clinical Trials Browser

Phase 2 × Lymphoma, Large B-Cell, Diffuse × durvalumab × Clear all

NCT03003520 2023-05-22

A Study of Durvalumab in Combination With R-CHOP or Lenalidomide Plus R-CHOP in Previously Untreated High-Risk Diffuse Large B-Cell Lymphoma

Phase 2 Completed

46 enrolled 20 charts

LymphoidSarcoma

Lymphoma, Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating

NCT03241017 2018-04-09

IDA-D

Phase 2 Withdrawn

Lymphoma, Large B-Cell, Diffuse